Literature DB >> 25179335

Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study.

Carlo Gagliotti1, Stefano Giordani2, Vincenzo Ciccarese2, Agostino Barozzi2, Antonio Giovinazzi3, Anne Marie Pietrantonio2, Maria Luisa Moro4, Giovanni Pinelli2, Mario Sarti2.   

Abstract

The present case-control study aimed to identify the main factors associated with colonization with carbapenemase-producing Klebsiella pneumoniae (CPKP) in acute care facilities. Administration of carbapenems (odds ratio [OR], 3.67; 95% confidence interval [CI], 1.37-9.83) and other antibiotics (OR, 2.83; 95% CI, 1.10-7.31) during the hospital stay was significantly associated with outcome. The design of this study, with concurrent selection of controls and matching by hospital ward and date of screening, provides a more accurate estimation of relative risks for CPKP colonization than previous investigations.
Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic prescription; Carbapenemase; Carrier; Klebsiella pneumoniae

Mesh:

Substances:

Year:  2014        PMID: 25179335     DOI: 10.1016/j.ajic.2014.05.028

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  7 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 2.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

3.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and associated clinical outcomes.

Authors:  Guanqun Dai; Yanling Xu; Hui Kong; Weiping Xie; Hong Wang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection.

Authors:  Guido Bertolini; Giovanni Nattino; Carlo Tascini; Daniele Poole; Bruno Viaggi; Greta Carrara; Carlotta Rossi; Daniele Crespi; Matteo Mondini; Martin Langer; Gian Maria Rossolini; Paolo Malacarne
Journal:  Intensive Care Med       Date:  2018-09-25       Impact factor: 17.440

Review 5.  Piperacillin-tazobactam as alternative to carbapenems for ICU patients.

Authors:  Benoit Pilmis; Vincent Jullien; Alexis Tabah; Jean-Ralph Zahar; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2017-11-10       Impact factor: 6.925

6.  Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution.

Authors:  Na Wang; Minghua Zhan; Jianhua Liu; Yao Wang; Yongwang Hou; Caiqing Li; Jia Li; Xuying Han; Jinlu Liu; Yong Chen; Jingjing Fan; Jianhua Tang; Wenhua Lu; Xinran Zhong; Zhihua Zhang; Wei Zhang
Journal:  Infect Drug Resist       Date:  2022-02-22       Impact factor: 4.003

7.  Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant K. pneumoniae: A Retrospective Study.

Authors:  Gefei He; Juanjuan Huang; Shiqiong Huang; Ji Sun; Yulv Zhou; Hong Tan; Hui Shen; Zhuan Li; Jiyang Liu
Journal:  Med Sci Monit       Date:  2020-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.